Filing Analysis
INNOVATE Corp. announced that its portfolio company, DBM Global, will be paying a cash dividend. The announcement was made via a press release on April 6, 2026, and disclosed under Item 8.01.
Key Facts
- The report was filed on April 6, 2026, regarding an event on the same date.
- Portfolio company DBM Global is the entity issuing the cash dividend.
- The disclosure was made under Item 8.01 (Other Events) and included a press release as Exhibit 99.1.
- INNOVATE Corp. is a holding company, making subsidiary dividends a key source of liquidity.
INNOVATE Corp. announced that MediBeacon, a company within its Life Sciences portfolio, has received the CE Mark for its Transdermal GFR Monitor and Reusable Sensor under the European Medical Device Regulation (MDR). This regulatory milestone allows the company to market and sell the kidney function monitoring system in the European Union.
Key Facts
- The announcement was made via a press release on March 31, 2026.
- The product involved is the MediBeacon® Transdermal GFR Monitor and Reusable Sensor.
- The CE Mark was granted under the current European Medical Device Regulation (MDR) standards.
- The filing was submitted under Item 8.01 (Other Events).
INNOVATE Corp. (VATE) announced its financial results for the fourth quarter and full year ended December 31, 2025. The company furnished a press release and an investor presentation, and hosted a conference call on March 26, 2026.
Key Facts
- Reported Q4 and FY 2025 financial results on March 26, 2026.
- Furnished Press Release as Exhibit 99.1.
- Furnished Investor Presentation as Exhibit 99.2.
- Conducted a conference call and webcast at 4:30 p.m. ET on the day of the filing.